Neutralization Profiles of HIV-1 Viruses from the VRC01 Antibody Mediated Prevention (AMP) Trials.
Nonhlanhla N. Mkhize,Anna Yssel,Haajira Kaldine,Rebecca T. van Dorsten,Amanda S. Davis,Nicolas Beaume,David Matten,Bronwen Lambson,Tandile Modise,Prudence Kgagudi,Talita York,Dylan H. Westfall,Elena E. Giorgi,Bette Korber,Colin Anthony,Rutendo E. Mapengo,Valerie Bekker, Elizabeth Domin,Amanda Eaton,Wenjie Deng,Allan DeCamp,Yunda Huang,Peter B. Gilbert, Asanda Gwashu-Nyangiwe,Ruwayhida Thebus,Nonkululeko Ndabambi,Dieter Mielke,Nyaradzo Mgodi,Shelly Karuna,Srilatha Edupuganti,Michael S. Seaman,Lawrence Corey,Myron S. Cohen,John Hural,M. Juliana McElrath,James I. Mullins,David Montefiori,Penny L. Moore,Carolyn Williamson,Lynn Morris PLOS PATHOGENS（2023）
Key words
Antibodies,HIV,HIV Infection
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper